There are plenty of ASX shares out there for investors to choose from.
To narrow things down, let's see what analysts are saying about three popular shares, courtesy of The Bull. Here's what they are recommending:

Image source: Getty Images
CSL Ltd (ASX: CSL)
The team at Fairmont Equities is bearish on this biotechnology company. It sees further downside risk for CSL shares and has named them as a sell. The equities firm thinks investors should wait until there is more confidence in its earnings growth outlook. It said:
This biotechnology giant was a market darling for a long time, but it's now failing to command a premium as uncertainty surrounding the company's US vaccine business is making it more difficult for investors to forecast future earnings. The recent departure of its chief executive also adds to the uncertainty.
From a technical perspective, the stock has topped out and is trending lower. In my view, this leaves further downside risk in the share price until investors feel more confident that CSL can lift earnings. The shares have fallen from $271.32 on August 18, 2025 to trade at $145.68 on February 26, 2026.
TechnologyOne Ltd (ASX: TNE)
Over at Morgans, its analysts are positive on this enterprise software provider and have named it as a buy this week.
The broker thinks it is one of the highest quality software companies and highlights its significant growth runway as a reason to buy. It explains:
TechnologyOne continues to stand out as one of Australia's highest quality software businesses, driven by loyal customers, recurring revenue and consistent expanding margins. Its cloud transition remains a major value driver, improving profitability from customers across government, education and the corporate sector.
TNE's reliable growth profile and strong balance sheet support its premium valuation, particularly given the company's long history of meeting or exceeding expectations. Given ongoing demand for mission critical software amid a significant runway for cloud migrations, we see TNE as a high conviction, long duration compounder.
Woodside Energy Group Ltd (ASX: WDS)
Fairmont Equities is more positive on Woodside and has named the energy giant as a buy this week.
It was pleased with its performance in FY 2025 and believes increasing demand for oil and gas leaves it well-positioned in 2026. The equities firm said:
Expected increasing demand for oil and gas in 2026 leaves me bullish about the energy sector. The company posted record annual production of 198.8 million barrels of oil equivalent in full year 2025, exceeding the guidance range. Record production offset lower realised prices.
The company's full year results met expectations, and the share price recently moved above a major resistance level. I expect the shares to trend higher and re-test previous peaks around $38 as calendar year 2026 unfolds. The shares have risen from $22.95 on January 8, 2026 to trade at $28.075 on February 26.